mbs303MBS303 is a CD20×CD3 T-cell-engaging bispecific antibody that has a novel 2:1 (CD20:CD3) confuration to kill malnant B cells. This dose-escalation phase Ⅰ trialMBS303-B-AX-0RAA Vitrohm Resistor Hardware Dummy pin datasheet, inventory, & pricing.